United States Molecular Diagnostics in Infectious Disease Testing Market Report 2016

United States Molecular Diagnostics in Infectious Disease Testing Market Report 2016

1 Molecular Diagnostics in Infectious Disease Testing Overview

1.1 Product Overview and Scope of Molecular Diagnostics in Infectious Disease Testing

1.2 Classification of Molecular Diagnostics in Infectious Disease Testing

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Molecular Diagnostics in Infectious Disease Testing

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Molecular Diagnostics in Infectious Disease Testing (2011-2021)

1.4.1 USA Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2011-2021)

1.4.2 USA Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2011-2021)

2 USA Molecular Diagnostics in Infectious Disease Testing Competition by Manufacturers

2.1 USA Molecular Diagnostics in Infectious Disease Testing Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Molecular Diagnostics in Infectious Disease Testing Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Molecular Diagnostics in Infectious Disease Testing Average Price by Manufactures (2015 and 2016)

2.4 Molecular Diagnostics in Infectious Disease Testing Market Competitive Situation and Trends

2.4.1 Molecular Diagnostics in Infectious Disease Testing Market Concentration Rate

2.4.2 Molecular Diagnostics in Infectious Disease Testing Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Molecular Diagnostics in Infectious Disease Testing Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Molecular Diagnostics in Infectious Disease Testing Sales and Market Share by Type (2011-2016)

3.2 USA Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2011-2016)

3.3 USA Molecular Diagnostics in Infectious Disease Testing Price by Type (2011-2016)

3.4 USA Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Type (2011-2016)

4 USA Molecular Diagnostics in Infectious Disease Testing Sales (Volume) by Application (2011-2016)

4.1 USA Molecular Diagnostics in Infectious Disease Testing Sales and Market Share by Application (2011-2016)

4.2 USA Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Molecular Diagnostics in Infectious Disease Testing Manufacturers Profiles/Analysis

5.1 Abbott Laboratories

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Abbott Laboratories Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 AdvanDx

5.2.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 AdvanDx Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Affymetrix

5.3.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Affymetrix Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Arcxis Biotechnologies

5.4.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Arcxis Biotechnologies Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Asuragen, Inc.

5.5.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Asuragen, Inc. Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 AutoGenomics, Inc.

5.6.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 AutoGenomics, Inc. Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Cepheid

5.7.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Cepheid Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 EraGen Biosciences

5.8.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 EraGen Biosciences Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 GenMark Diagnostics, Inc.

5.9.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 GenMark Diagnostics, Inc. Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Myconostica

5.10.2 Molecular Diagnostics in Infectious Disease Testing Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Myconostica Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Myriad Genetics, Inc

5.12 NorDiag ASA (The DiaSorin Group)

5.13 Qiagen N.V

5.14 Quidel

5.15 Roche Diagn

6 Molecular Diagnostics in Infectious Disease Testing Manufacturing Cost Analysis

6.1 Molecular Diagnostics in Infectious Disease Testing Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Molecular Diagnostics in Infectious Disease Testing

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Molecular Diagnostics in Infectious Disease Testing Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Molecular Diagnostics in Infectious Disease Testing Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Molecular Diagnostics in Infectious Disease Testing Market Forecast (2016-2021)

10.1 USA Molecular Diagnostics in Infectious Disease Testing Sales, Revenue Forecast (2016-2021)

10.2 USA Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Type (2016-2021)

10.3 USA Molecular Diagnostics in Infectious Disease Testing Sales Forecast by Application (2016-2021)

10.4 Molecular Diagnostics in Infectious Disease Testing Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Molecular Diagnostics in Infectious Disease Testing

Table Classification of Molecular Diagnostics in Infectious Disease Testing

Figure USA Sales Market Share of Molecular Diagnostics in Infectious Disease Testing by Type in 2015

Table Application of Molecular Diagnostics in Infectious Disease Testing

Figure USA Sales Market Share of Molecular Diagnostics in Infectious Disease Testing by Application in 2015

Figure USA Molecular Diagnostics in Infectious Disease Testing Sales and Growth Rate (2011-2021)

Figure USA Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2011-2021)

Table USA Molecular Diagnostics in Infectious Disease Testing Sales of Key Manufacturers (2015 and 2016)

Table USA Molecular Diagnostics in Infectious Disease Testing Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Molecular Diagnostics in Infectious Disease Testing Sales Share by Manufacturers

Figure 2016 Molecular Diagnostics in Infectious Disease Testing Sales Share by Manufacturers

Table USA Molecular Diagnostics in Infectious Disease Testing Revenue by Manufacturers (2015 and 2016)

Table USA Molecular Diagnostics in Infectious Disease Testing Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Molecular Diagnostics in Infectious Disease Testing Revenue Share by Manufacturers

Table 2016 USA Molecular Diagnostics in Infectious Disease Testing Revenue Share by Manufacturers

Table USA Market Molecular Diagnostics in Infectious Disease Testing Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Molecular Diagnostics in Infectious Disease Testing Average Price of Key Manufacturers in 2015

Figure Molecular Diagnostics in Infectious Disease Testing Market Share of Top 3 Manufacturers

Figure Molecular Diagnostics in Infectious Disease Testing Market Share of Top 5 Manufacturers

Table USA Molecular Diagnostics in Infectious Disease Testing Sales by Type (2011-2016)

Table USA Molecular Diagnostics in Infectious Disease Testing Sales Share by Type (2011-2016)

Figure USA Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Type in 2015

Table USA Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2011-2016)

Table USA Molecular Diagnostics in Infectious Disease Testing Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Molecular Diagnostics in Infectious Disease Testing by Type (2011-2016)

Table USA Molecular Diagnostics in Infectious Disease Testing Price by Type (2011-2016)

Figure USA Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Type (2011-2016)

Table USA Molecular Diagnostics in Infectious Disease Testing Sales by Application (2011-2016)

Table USA Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application (2011-2016)

Figure USA Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Application in 2015

Table USA Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2011-2016)

Figure USA Molecular Diagnostics in Infectious Disease Testing Sales Growth Rate by Application (2011-2016)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table AdvanDx Basic Information List

Table AdvanDx Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table AdvanDx Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Affymetrix Basic Information List

Table Affymetrix Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Affymetrix Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Arcxis Biotechnologies Basic Information List

Table Arcxis Biotechnologies Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Arcxis Biotechnologies Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Asuragen, Inc. Basic Information List

Table Asuragen, Inc. Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Asuragen, Inc. Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table AutoGenomics, Inc. Basic Information List

Table AutoGenomics, Inc. Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table AutoGenomics, Inc. Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Cepheid Basic Information List

Table Cepheid Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cepheid Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table EraGen Biosciences Basic Information List

Table EraGen Biosciences Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table EraGen Biosciences Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table GenMark Diagnostics, Inc. Basic Information List

Table GenMark Diagnostics, Inc. Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table GenMark Diagnostics, Inc. Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Myconostica Basic Information List

Table Myconostica Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Myconostica Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Myriad Genetics, Inc Basic Information List

Table Myriad Genetics, Inc Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Myriad Genetics, Inc Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table NorDiag ASA (The DiaSorin Group) Basic Information List

Table NorDiag ASA (The DiaSorin Group) Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table NorDiag ASA (The DiaSorin Group) Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Qiagen N.V Basic Information List

Table Qiagen N.V Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Qiagen N.V Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Quidel Basic Information List

Table Quidel Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Quidel Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Roche Diagn Basic Information List

Table Roche Diagn Molecular Diagnostics in Infectious Disease Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Diagn Molecular Diagnostics in Infectious Disease Testing Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Molecular Diagnostics in Infectious Disease Testing

Figure Manufacturing Process Analysis of Molecular Diagnostics in Infectious Disease Testing

Figure Molecular Diagnostics in Infectious Disease Testing Industrial Chain Analysis

Table Raw Materials Sources of Molecular Diagnostics in Infectious Disease Testing Major Manufacturers in 2015

Table Major Buyers of Molecular Diagnostics in Infectious Disease Testing

Table Distributors/Traders List

Figure USA Molecular Diagnostics in Infectious Disease Testing Production and Growth Rate Forecast (2016-2021)

Figure USA Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate Forecast (2016-2021)

Table USA Molecular Diagnostics in Infectious Disease Testing Production Forecast by Type (2016-2021)

Table USA Molecular Diagnostics in Infectious Disease Testing Consumption Forecast by Application (2016-2021)